Trinicalm Plus Tablet is a combination therapy formulated to manage psychotic disorders, schizophrenia, and associated movement disorders caused by antipsychotic medications. This formulation combines an anticholinergic agent with a low-dose antipsychotic, offering effective symptom control while minimizing drug-induced extrapyramidal side effects.

• Benzhexol 2 MG helps prevent and reduce tremors, stiffness, and involuntary movements often caused by antipsychotic therapy.

• Trifluoperazine 5 MG is a first-generation antipsychotic that helps manage hallucinations, delusions, agitation, and severe anxiety associated with psychotic conditions.

This combination is suitable for patients requiring antipsychotic treatment with improved tolerability and enhanced compliance.